VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
13 hedge funds and large institutions have $493K invested in Virpax Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$4.98K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$94 |
3 |
3
Wells Fargo
San Francisco,
California
|
$50 |